The Oncology Institute, Inc. TOI FFS accounts receivable — Total Assets
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s ffs accounts receivable — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s FFS accounts receivable — total assets?
- The Oncology Institute, Inc. (TOI) reported FFS accounts receivable — total assets of $33.64M in Q1 2026.
- How has The Oncology Institute, Inc.'s FFS accounts receivable — total assets changed year-over-year?
- The Oncology Institute, Inc.'s FFS accounts receivable — total assets increased by 17.6% year-over-year, from $28.59M to $33.64M.
- What does FFS accounts receivable — total assets mean?
- This metric measures the proportion of total assets tied up in fee-for-service (FFS) accounts receivable, representing the outstanding balance owed by payers for oncology services rendered. It serves as a key indicator of revenue cycle efficiency and the liquidity risk associated with the company's primary service delivery model. A higher ratio may suggest delays in reimbursement processing or potential challenges in collecting payments from insurance providers.